ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,426.83
0.08%
Dow Jones
39,982.83
-0.05%
Gold vs US Dollar
2,417.305
-0.09%
Brent Oil
83.275
-0.38%
Bitcoin
67,002.95
1.27%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
20/05/202414:30Alliance NewsAlliance NewsCora Gold says focused on Sanankoro project as annual loss widensLSE:CORACora Gold Limited
20/05/202414:30PR Newswire (US)Career Fair • Open-to-the-Public • Renaissance Waverly Atlanta • Saturday June 29th, 2024, 9:30AM--1:30PM
20/05/202414:30PR Newswire (US)Academy of Art University and San Francisco Fire Department Unveil Historical Mural by Student Artist Carmynn Zhang at SFFD Headquarters
20/05/202414:30PR Newswire (US)Cineverse Expands the Bob Ross Universe with Remastered Episodes in HD & 4K along with a New Gallery Collection SeriesNASDAQ:CNVSCineverse Corporation
20/05/202414:30PR Newswire (US)Rila Therapeutics Announces Dosing of First Cohort in Phase 1 Clinical Trial of RLA-23174, a First-In-Class HIPK2 Allosteric Inhibitor, For Treatment of Chronic Kidney Disease and Fibrosis
20/05/202414:30PR Newswire (US)Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
20/05/202414:29Alliance NewsAlliance NewsBradda reaches settlement agreement over fraudulent paymentLSE:BHLBradda Head Lithium Limited
20/05/202414:29Alliance NewsAlliance NewsBradda reaches settlement agreement over fraudulent paymentLSE:BHLBradda Head Lithium Limited
20/05/202414:28Alliance NewsAlliance NewsFOREX MARKET: Dollar on backfoot ahead of quiet week
20/05/202414:28PR Newswire (US)BingX Marks Sixth Anniversary with Comprehensive Global Expansion Strategy
20/05/202414:28PR Newswire (US)Keep Electrical Safety a Priority for a Bright and Enjoyable Summer SeasonNYSE:FEFirstEnergy Corp
20/05/202414:28PR Newswire (US)Youlife International and Distoken Acquisition Corporation Announce Definitive Business Combination Agreement
20/05/202414:26UK RegulatoryNorges Bank - Form 8.3 - Spirent Communications PlcLSE:SPTSpirent Communications Plc
20/05/202414:25Alliance NewsAlliance NewsIN BRIEF: Airtel Africa confirms repayment of Netherlands bondLSE:AAFAirtel Africa Plc
20/05/202414:25UK RegulatoryForm 8.3 - Abrdn European Logistics Income PlcLSE:RATRathbones Group Plc
20/05/202414:25PR Newswire (US)DLT ENTERTAINMENT LAUNCHES 80'S SITCOM FLASHBACK, FIRST FAST CHANNEL CURATED TO CELEBRATE THE ZANY OLD SCHOOL TV COMEDIES OF THE ICONIC EIGHTIES
20/05/202414:24Alliance NewsAlliance NewsIN BRIEF: Centrica completes tender offer for GBP415 millionLSE:CNACentrica Plc
20/05/202414:24Alliance NewsAlliance NewsIN BRIEF: Centrica completes tender offer for GBP415 millionLSE:CNACentrica Plc
20/05/202414:24Alliance NewsAlliance NewsKefi launches Tulu Kapi mining project amid all-time high gold pricesLSE:KEFIKefi Gold And Copper Plc
20/05/202414:24PR Newswire (US)Groundbreaking Advance in Brain Science: Creating Human Blood-Brain Barrier 'Assembloids'
20/05/202414:21Alliance NewsAlliance NewsValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grantLSE:VALValirx Plc
20/05/202414:20UK RegulatoryNorges Bank - Form 8.3 - Virgin Money UK PLCLSE:VMUKVirgin Money Uk Plc
20/05/202414:18PR Newswire (US)TechTorch Acquires AstuteForce to Bolster Salesforce Expertise and Expand Commercial Excellence Practice
20/05/202414:17PR Newswire (US)Old World Christmas® Announces New Partnerships for 2025
20/05/202414:16PR Newswire (US)Introducing Bench Solutions Set to Revolutionize Public Seating
20/05/202414:15PR Newswire (US)Grasons Celebrates the Legacy of Loved Ones with Estate Sales This Memorial Day
20/05/202414:15PR Newswire (US)CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTIONNYSE:CRTCross Timbers Royalty Trust
20/05/202414:15PR Newswire (US)San Juan Basin Royalty Trust Declares No Cash Distribution for May 2024 and Announces Production Costs in Excess of ProceedsNYSE:SJTSan Juan Basin Royalty Trust
20/05/202414:15PR Newswire (US)GrubMarket Acquires Butter to Strengthen its AI-Powered Software Capabilities for the American Food Supply Chain
20/05/202414:15PR Newswire (US)Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development

Your Recent History

NASDAQ
CHSCP
CHS
NASDAQ
ACT
Enact
NASDAQI
NQCAPSTN
Capital Strength Net Tot...
NASDAQ
BOOM
DMC Global
NYSE
LXP
LXP Industrial
NASDAQI
CRSPCDT
CRSP US Consumer Discret...
LSE
TRP
Tower Resources
TSXV
PLY
Playfair Mining
NYSE
KAP
TG
AEX
Chubb
NASDAQ
GRMN
Garmin
LSE
AQSG
Aquila Services
LSE
AUK
Aukett Swanke
COIN
DELIVUSD
NYSE
DKL
Delek Logistics Partners
NASDAQ
LQDA
Liquidia
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved